Healthcare's AI race heats up

Eli Lilly's experimental drug retatrutide led to more than double the weight loss compared to Ozempic in type 2 diabetes patients over 16 months. Meanwhile, digital healthcare company Ro is advancing AI agents to personalize health management using patient data.